Effects of Resmetirom on Metabolic‐Dysfunction Associated Steatohepatitis in Patients With Weight Loss and/or Diabetes Taking Glucagon‐Like Peptide‐1 Receptor Agonists and Other Diabetes Therapies: A Secondary Analysis of the <scp>MAESTRO</scp> ‐ <sc

Authors

Mary Eugenia Rinella (ORCID: https://orcid.org/0000-0003-0620-9705)
Meena B. Bansal (ORCID: https://orcid.org/0000-0002-7501-2191)
Mazen Noureddin (ORCID: https://orcid.org/0000-0003-2127-2040)
Rohit Seth Loomba (ORCID: https://orcid.org/0000-0002-4845-9991)
Naim Alkhouri (ORCID: https://orcid.org/0000-0001-9872-2391)
Dominic Labriola
Raul C. Camacho
Rebecca Taub

Institutions

University of California San Diego (US)
University of Chicago (US)
Methodist Hospital (US)
Pinnacle Clinical Research (US)
Conceptual Mindworks (United States) (US)
Houston Institute for Clinical Research (US)
Madrigal Pharmaceuticals (United States) (US)
Icahn School of Medicine at Mount Sinai (US)

Publication Details

Journal: Alimentary Pharmacology & Therapeutics
Published: 2025-10-23
DOI: https://doi.org/10.1111/apt.70382
Citations: 4
Primary Topic: Liver Disease Diagnosis and Treatment
Type: article
Field-Weighted Citation Impact: 5.42

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Effects of Resmetirom on Metabolic‐Dysfunction Associated Steatohepatitis in Patients With Weight Loss and/or Diabetes Taking Glucagon‐Like Peptide‐1 Receptor Agonists and Other Diabetes Therapies: A Secondary Analysis of the MAESTRO ‐ <sc

Mary Eugenia Rinella, Meena B. Bansal, Mazen Noureddin, Rohit Seth Loomba et al.

Oct 23, 2025

4 citations

Alimentary Pharmacology & Therapeutics

Liver Disease Diagnosis and Treatment

5.42

article

Effects of Resmetirom on Metabolic‐Dysfunction Associated Steatohepatitis in Patients With Weight Loss and/or Diabetes Taking Glucagon‐Like Peptide‐1 Receptor Agonists and Other Diabetes Therapies: A Secondary Analysis of the MAESTRO ‐ <sc

Mary Eugenia Rinella, Meena B. Bansal, Mazen Noureddin, Rohit Seth Loomba, Naim Alkhouri, Dominic Labriola, Raul C. Camacho, Rebecca Taub

October 23, 2025article en

4 citations

Abstract

No abstract available for this paper.

Alimentary Pharmacology & TherapeuticsVol. 62(11-12)

University of California San Diego (US), University of Chicago (US), Methodist Hospital (US), Pinnacle Clinical Research (US), Conceptual Mindworks (United States) (US), Houston Institute for Clinical Research (US), Madrigal Pharmaceuticals (United States) (US), Icahn School of Medicine at Mount Sinai (US)

Openalex Percentile: Top 4%

Liver Disease Diagnosis and Treatment

5.42

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Effects of Resmetirom on Metabolic‐Dysfunction Associated Steatohepatitis in Patients With Weight Loss and/or Diabetes Taking Glucagon‐Like Peptide‐1 Receptor Agonists and Other Diabetes Therapies: A Secondary Analysis of the <scp>MAESTRO</scp> ‐ <sc — Mary Eugenia Rinella, Meena B. Bansal, et al. · Alimentary Pharmacology & Therapeutics (2025) | TGRS Research Map | TGRS